title: Reduced MTHFD1 activity in male mice perturbs folate- and choline-dependent one-carbon metabolism as well as transsulfuration.
abstract: Impaired utilization of folate is caused by insufficient dietary intake and/or genetic variation and has been shown to prompt changes in related pathways, including choline and methionine metabolism. These pathways have been shown to be sensitive to variation within the Mthfd1 gene, which codes for a folate-metabolizing enzyme responsible for generating 1-carbon (1-C)-substituted folate derivatives. The Mthfd1(gt/+) mouse serves as a potential model of human Mthfd1 loss-of-function genetic variants that impair MTHFD1 function. This study investigated the effects of the Mthfd1(gt/+) genotype and folate intake on markers of choline, folate, methionine, and transsulfuration metabolism. Male Mthfd1(gt/+) and Mthfd1(+/+) mice were randomly assigned at weaning (3 wk of age) to either a control (2 mg/kg folic acid) or folate-deficient (0 mg/kg folic acid) diet for 5 wk. Mice were killed at 8 wk of age following 12 h of food deprivation; blood and liver samples were analyzed for choline, methionine, and transsulfuration biomarkers. Independent of folate intake, mice with the Mthfd1(gt/+) genotype had higher hepatic concentrations of choline (P = 0.005), betaine (P = 0.013), and dimethylglycine (P = 0.004) and lower hepatic concentrations of glycerophosphocholine (P = 0.002) relative to Mthfd1(+/+) mice. Mthfd1(gt/+) mice also had higher plasma concentrations of homocysteine (P = 0.0016) and cysteine (P < 0.001) as well as lower plasma concentrations of methionine (P = 0.0003) and cystathionine (P = 0.011). The metabolic alterations observed in Mthfd1(gt/+) mice indicate perturbed choline and folate-dependent 1-C metabolism and support the future use of Mthfd1(gt/+) mice as a tool to investigate the impact of impaired 1-C metabolism on disease outcomes.
authors.affiliation: Division of Nutritional Science, Cornell University, Ithaca, NY, USA.
authors.forename: Martha S
authors.initials: MS
authors.lastname: Field
authors.forename: Kelsey S
authors.initials: KS
authors.lastname: Shields
authors.forename: Elena V
authors.initials: EV
authors.lastname: Abarinov
authors.forename: Olga V
authors.initials: OV
authors.lastname: Malysheva
authors.forename: Robert H
authors.initials: RH
authors.lastname: Allen
authors.forename: Sally P
authors.initials: SP
authors.lastname: Stabler
authors.forename: Jessica A
authors.initials: JA
authors.lastname: Ash
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Strupp
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: Stover
authors.forename: Marie A
authors.initials: MA
authors.lastname: Caudill
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D002794:Choline / Q000097:blood / Q000378:metabolism*; D003545:Cysteine / Q000097:blood / Q000378:metabolism; D004195:Disease Models, Animal; D005494:Folic Acid Deficiency / Q000097:blood / Q000201:enzymology* / Q000378:metabolism; D006579:Heterozygote; D006710:Homocysteine / Q000097:blood / Q000378:metabolism; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D008715:Methionine / Q000097:blood / Q000378:metabolism; D008745:Methylation; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP) / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D016254:Mutagenesis, Insertional; D050505:Mutant Proteins / Q000378:metabolism; D011897:Random Allocation
chemical_list: D015415:Biomarkers; D007527:Isoenzymes; D050505:Mutant Proteins; D006710:Homocysteine; D008715:Methionine; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP); D003545:Cysteine; D002794:Choline